Skip to main content
Top
Published in: Head and Neck Pathology 3/2008

01-09-2008 | Original Paper

Human Kallikrein 8 Expression in Salivary Gland Tumors

Authors: Mark R. Darling, Sam Tsai, Linda Jackson-Boeters, Thomas D. Daley, Eleftherios P. Diamandis

Published in: Head and Neck Pathology | Issue 3/2008

Login to get access

Abstract

The human kallikrein 8 protein (KLK8) is expressed in many normal tissues including esophagus, skin, testis, tonsil, kidney, breast, and salivary gland, and is found in biological fluids including breast milk, amniotic fluid, seminal fluid and serum. It has also been shown to be a biomarker and prognostic factor for breast cancer. The aim of this study was to determine whether KLK8 is expressed in salivary gland tissues and salivary gland tumors (both benign and malignant), in order to compare normal with tumor tissues. Pleomorphic adenomas, adenoid cystic carcinomas, polymorphous low grade adenocarcinomas, acinic cell carcinomas, mucoepidermoid carcinomas, and adenocarcinomas NOS of both minor and major salivary glands were examined. The results of this study indicate that most salivary gland tumors show high levels of expression of KLK8.
Literature
1.
go back to reference Diamandis EP, Yousef GM, Luo LY. The human kallikrein gene family—implications in carcinogenesis. Trends Endocrinol Metab. 2000;11:54–60.PubMedCrossRef Diamandis EP, Yousef GM, Luo LY. The human kallikrein gene family—implications in carcinogenesis. Trends Endocrinol Metab. 2000;11:54–60.PubMedCrossRef
2.
go back to reference Yousef GM, Diamandis EP. The new human tissue kallikrein gene family: structure, function and association to disease. Endocr Rev. 2001;22:184–204.PubMedCrossRef Yousef GM, Diamandis EP. The new human tissue kallikrein gene family: structure, function and association to disease. Endocr Rev. 2001;22:184–204.PubMedCrossRef
3.
go back to reference Borgono CA, Michael IP, Diamandis EP. Human tissue kallikreins: physiologic roles and applications in cancer. Mol Cancer Res. 2004;2:257–80.PubMed Borgono CA, Michael IP, Diamandis EP. Human tissue kallikreins: physiologic roles and applications in cancer. Mol Cancer Res. 2004;2:257–80.PubMed
4.
go back to reference Borgono CA, Diamandis EP. The emerging roles of human tissue kallikreins in cancer. Nat Rev Cancer. 2004;4:876–90.PubMedCrossRef Borgono CA, Diamandis EP. The emerging roles of human tissue kallikreins in cancer. Nat Rev Cancer. 2004;4:876–90.PubMedCrossRef
5.
go back to reference Yousef GM, Diamandis EP. Human tissue kallikreins: a new enzymatic cascade pathway? Biol Chem. 2002;383:1045–57.PubMedCrossRef Yousef GM, Diamandis EP. Human tissue kallikreins: a new enzymatic cascade pathway? Biol Chem. 2002;383:1045–57.PubMedCrossRef
6.
go back to reference Rajapakse S, Ogiwara K, Takano N, et al. Biochemical characterization of human kallikrein 8 and its possible involvement in the degradation of extracellular matrix proteins. FEBS Lett. 2005;579:6879–84.PubMedCrossRef Rajapakse S, Ogiwara K, Takano N, et al. Biochemical characterization of human kallikrein 8 and its possible involvement in the degradation of extracellular matrix proteins. FEBS Lett. 2005;579:6879–84.PubMedCrossRef
7.
go back to reference Diamandis EP, Yousef GM. Human tissue kallikreins: a family of new cancer biomarkers. Clin Chem. 2002;48:1198–1205.PubMed Diamandis EP, Yousef GM. Human tissue kallikreins: a family of new cancer biomarkers. Clin Chem. 2002;48:1198–1205.PubMed
8.
go back to reference Diamandis EP, Yousef GM. Human tissue kallikrein gene family: a rich source of novel disease biomarkers. Expert Rev Mol Diagn. 2001;1:182–90.PubMedCrossRef Diamandis EP, Yousef GM. Human tissue kallikrein gene family: a rich source of novel disease biomarkers. Expert Rev Mol Diagn. 2001;1:182–90.PubMedCrossRef
9.
go back to reference Obiezu C, Diamandis E. Human tissue kallikrein family: applications in cancer. Cancer Lett. 2005;224:1–22.PubMed Obiezu C, Diamandis E. Human tissue kallikrein family: applications in cancer. Cancer Lett. 2005;224:1–22.PubMed
10.
go back to reference Petraki CD, Papanastasiou PA, Karavana VN, et al. Cellular distribution of human tissue kallikreins: immunohistochemical localization. Biol Chem. 387;2006:653–63.PubMedCrossRef Petraki CD, Papanastasiou PA, Karavana VN, et al. Cellular distribution of human tissue kallikreins: immunohistochemical localization. Biol Chem. 387;2006:653–63.PubMedCrossRef
11.
go back to reference Yoshida S, Taniguchi M, Hirata A, et al. Sequence analysis and expression of human neuropsin cDNA and gene. Gene. 1998;213:9–16.PubMedCrossRef Yoshida S, Taniguchi M, Hirata A, et al. Sequence analysis and expression of human neuropsin cDNA and gene. Gene. 1998;213:9–16.PubMedCrossRef
12.
go back to reference Kishi T, Grass L, Soosaipillai A, et al. Human kallikrein 8: immunoassay development and identification in tissue extracts and biological fluids. Clin Chem. 2003;49:87–96.PubMedCrossRef Kishi T, Grass L, Soosaipillai A, et al. Human kallikrein 8: immunoassay development and identification in tissue extracts and biological fluids. Clin Chem. 2003;49:87–96.PubMedCrossRef
13.
go back to reference Ellis GL, Auclair PL. Tumors of the salivary glands. In: Rosai J, Sobin LH, editors. Atlas of tumor pathology, Third Series, Fascicle 17. Washington, D.C.: Armed Forces Institute of Pathology; 1996. p. 39–56, 155–228. Ellis GL, Auclair PL. Tumors of the salivary glands. In: Rosai J, Sobin LH, editors. Atlas of tumor pathology, Third Series, Fascicle 17. Washington, D.C.: Armed Forces Institute of Pathology; 1996. p. 39–56, 155–228.
14.
go back to reference Black MH, Magklara A, Obiezu CV, et al. Development of an ultrasensitive immunoassay for human glandular kallikrein with no cross-reactivity from prostate-specific antigen. Clin Chem. 1999;45:790–9.PubMed Black MH, Magklara A, Obiezu CV, et al. Development of an ultrasensitive immunoassay for human glandular kallikrein with no cross-reactivity from prostate-specific antigen. Clin Chem. 1999;45:790–9.PubMed
15.
go back to reference Allred DC, Clark GM, Elledge R, et al. Association of p53 protein expression with tumor cell proliferation rate and clinical outcome in node-negative breast cancer. J Natl Cancer Inst. 1993;85:200–6.PubMedCrossRef Allred DC, Clark GM, Elledge R, et al. Association of p53 protein expression with tumor cell proliferation rate and clinical outcome in node-negative breast cancer. J Natl Cancer Inst. 1993;85:200–6.PubMedCrossRef
16.
go back to reference Tuck AB, O’Malley FP, Singhal H, et al. Osteopontin expression in a group of lymph node negative breast cancer patients. Int J Cancer. 1998;79:502–8.PubMedCrossRef Tuck AB, O’Malley FP, Singhal H, et al. Osteopontin expression in a group of lymph node negative breast cancer patients. Int J Cancer. 1998;79:502–8.PubMedCrossRef
17.
go back to reference Kishi T, Grass L, Soosaipillai A, et al. Human kallikrein 8, a novel biomarker for ovarian carcinoma. Cancer Res. 2003;63:2771–4.PubMed Kishi T, Grass L, Soosaipillai A, et al. Human kallikrein 8, a novel biomarker for ovarian carcinoma. Cancer Res. 2003;63:2771–4.PubMed
18.
go back to reference Yousef GM, Polymeris ME, Yacoub GM, et al. Parallel overexpression of seven kallikrein genes in ovarian cancer. Cancer Res. 2003;63:2223–7.PubMed Yousef GM, Polymeris ME, Yacoub GM, et al. Parallel overexpression of seven kallikrein genes in ovarian cancer. Cancer Res. 2003;63:2223–7.PubMed
19.
go back to reference Magklara A, Scorilas A, Katsaros D, et al. The human KLK8 (neuropsin/ovasin) gene: identification of two novel splice variants and its prognostic value in ovarian cancer. Clin Cancer Res. 2001;7:806–11.PubMed Magklara A, Scorilas A, Katsaros D, et al. The human KLK8 (neuropsin/ovasin) gene: identification of two novel splice variants and its prognostic value in ovarian cancer. Clin Cancer Res. 2001;7:806–11.PubMed
20.
go back to reference Shigemasa K, Tian X, Gu L, et al. Human kallikrein 8 (KLK8/TADG-14) expression is associated with an early clinical stage and favorable prognosis in ovarian cancer. Oncol Rep. 2004;11:1153–9.PubMed Shigemasa K, Tian X, Gu L, et al. Human kallikrein 8 (KLK8/TADG-14) expression is associated with an early clinical stage and favorable prognosis in ovarian cancer. Oncol Rep. 2004;11:1153–9.PubMed
21.
go back to reference Borgono CA, Kishi T, Scorilas A, et al. Human kallikrein 8 protein is a favorable prognostic marker in ovarian cancer. Clin Cancer Res. 2006;12:1487–93.PubMedCrossRef Borgono CA, Kishi T, Scorilas A, et al. Human kallikrein 8 protein is a favorable prognostic marker in ovarian cancer. Clin Cancer Res. 2006;12:1487–93.PubMedCrossRef
22.
go back to reference Yousef GM, Yacoub GM, Polymeris ME, et al. Kallikrein gene downregulation in breast cancer. Br J Cancer. 2004;90:167–72.PubMedCrossRef Yousef GM, Yacoub GM, Polymeris ME, et al. Kallikrein gene downregulation in breast cancer. Br J Cancer. 2004;90:167–72.PubMedCrossRef
23.
go back to reference Paliouras M, Diamandis EP. Coordinated steroid hormone-dependent and independent expression of multiple kallikreins in breast cancer cell lines. Breast Cancer Res Treat. 2007;102:7–18.PubMedCrossRef Paliouras M, Diamandis EP. Coordinated steroid hormone-dependent and independent expression of multiple kallikreins in breast cancer cell lines. Breast Cancer Res Treat. 2007;102:7–18.PubMedCrossRef
24.
go back to reference Cané S, Bignotti E, Bellone S, et al. The novel serine protease tumor-associated differentially expressed gene-14(KLK8/Neuropsin/Ovasin) is highly overexpressed in cervical cancer. Am J Obstet Gynecol. 2004;190:60–6.PubMedCrossRef Cané S, Bignotti E, Bellone S, et al. The novel serine protease tumor-associated differentially expressed gene-14(KLK8/Neuropsin/Ovasin) is highly overexpressed in cervical cancer. Am J Obstet Gynecol. 2004;190:60–6.PubMedCrossRef
25.
go back to reference Jin H, Nagai N, Shigemasa K, et al. Expression of tumor-associated differentially expressed Gene-14 (TADG-14/KLK8) and its protein KLK8 in uterine endometria and endometrial carcinomas. Tumour Biol. 2006;27:274–82.PubMedCrossRef Jin H, Nagai N, Shigemasa K, et al. Expression of tumor-associated differentially expressed Gene-14 (TADG-14/KLK8) and its protein KLK8 in uterine endometria and endometrial carcinomas. Tumour Biol. 2006;27:274–82.PubMedCrossRef
26.
go back to reference Sher YP, Chou CC, Chou RH, et al. Human kallikrein 8 protease confers a favorable clinical outcome in non-small cell lung cancer by suppressing tumor cell invasiveness. Cancer Res. 2006;66:11763–70.PubMedCrossRef Sher YP, Chou CC, Chou RH, et al. Human kallikrein 8 protease confers a favorable clinical outcome in non-small cell lung cancer by suppressing tumor cell invasiveness. Cancer Res. 2006;66:11763–70.PubMedCrossRef
27.
go back to reference Kishi T, Cloutier SM, Kundig C, et al. Activation and enzymatic characterization of recombinant human kallikrein 8. Biol Chem. 2006;387:723–31.PubMedCrossRef Kishi T, Cloutier SM, Kundig C, et al. Activation and enzymatic characterization of recombinant human kallikrein 8. Biol Chem. 2006;387:723–31.PubMedCrossRef
28.
go back to reference Pampalakis G, Sotiropoulou G. Tissue kallikrein proteolytic cascade pathways in normal physiology and cancer. Biochim Biophys Acta. 2007;1776:22–31.PubMed Pampalakis G, Sotiropoulou G. Tissue kallikrein proteolytic cascade pathways in normal physiology and cancer. Biochim Biophys Acta. 2007;1776:22–31.PubMed
29.
go back to reference Emami N, Diamandis EP. Human tissue kallikreins: a road under construction. Clin Chim Acta. 2007;381:78–84.PubMedCrossRef Emami N, Diamandis EP. Human tissue kallikreins: a road under construction. Clin Chim Acta. 2007;381:78–84.PubMedCrossRef
30.
go back to reference Yoon H, Laxmikanthan G, Lee J, et al. Activation profiles and regulatory cascades of the human kallikrein-related peptidases. J Biol Chem. 2007;282:31852–64.PubMedCrossRef Yoon H, Laxmikanthan G, Lee J, et al. Activation profiles and regulatory cascades of the human kallikrein-related peptidases. J Biol Chem. 2007;282:31852–64.PubMedCrossRef
31.
go back to reference Darling MR, Jackson-Boeters L, Daley TD, et al. Human kallikrein 6 expression in salivary gland tumors. J Histochem Cytochem. 2006;54:337–42.PubMedCrossRef Darling MR, Jackson-Boeters L, Daley TD, et al. Human kallikrein 6 expression in salivary gland tumors. J Histochem Cytochem. 2006;54:337–42.PubMedCrossRef
32.
go back to reference Darling MR, Jackson-Boeters L, Daley TD, et al. Human kallikrein 13 expression in salivary gland tumors. Int J Biol Markers. 2006;21:106–10.PubMed Darling MR, Jackson-Boeters L, Daley TD, et al. Human kallikrein 13 expression in salivary gland tumors. Int J Biol Markers. 2006;21:106–10.PubMed
33.
go back to reference Darling MR, Tsai S, Jackson-Boeters L, et al. Human kallikrein 3 (prostate specific antigen) and human kallikrein 5 expression in salivary gland tumors. Int J Biol Markers. 2006;21:201–5.PubMed Darling MR, Tsai S, Jackson-Boeters L, et al. Human kallikrein 3 (prostate specific antigen) and human kallikrein 5 expression in salivary gland tumors. Int J Biol Markers. 2006;21:201–5.PubMed
34.
go back to reference Paliouras M, Diamandis EP. The kallikrein world: an update on the human tissue kallikreins. Biol Chem 2006;387:643–52.PubMedCrossRef Paliouras M, Diamandis EP. The kallikrein world: an update on the human tissue kallikreins. Biol Chem 2006;387:643–52.PubMedCrossRef
Metadata
Title
Human Kallikrein 8 Expression in Salivary Gland Tumors
Authors
Mark R. Darling
Sam Tsai
Linda Jackson-Boeters
Thomas D. Daley
Eleftherios P. Diamandis
Publication date
01-09-2008
Publisher
Humana Press Inc
Published in
Head and Neck Pathology / Issue 3/2008
Electronic ISSN: 1936-0568
DOI
https://doi.org/10.1007/s12105-008-0068-z

Other articles of this Issue 3/2008

Head and Neck Pathology 3/2008 Go to the issue

Sine qua none Radiology-Pathology

Bilateral Warthin Tumors of the Parotid Gland